Medicare Enrolled

Dr. Daniel Pak, M.D.

Anesthesiology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
6414 FANNIN ST, Houston, TX 77030
7135006201
In practice since 2013 (12 years)
NPI: 1558705301 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pak

Dr. Daniel Pak is an anesthesiology specialist in Houston, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Pak performed 2,257 Medicare services across 787 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pak received a total of $78,637 from 20 pharmaceutical and/or device companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pak is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 4% volume in TX $78,637 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,257
Medicare services
Top 4% in TX for anesthesiology
787
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~188 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Steroid injection (triamcinolone) 759 $1 $3
Dexamethasone injection (steroid) 543 $0 $2
Office visit, established patient (30-39 min) 372 $109 $500
New patient office visit (45-59 min) 102 $144 $725
Office visit, established patient (20-29 min) 65 $79 $350
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level 39 $258 $2,300
Injection of substance into lower spine canal using imaging guidance 38 $238 $2,050
Injection of lower or sacral spine facet joint using imaging guidance, single level 38 $219 $1,850
Injection of lower or sacral spine facet joint using imaging guidance, second level 37 $113 $400
Insertion of spinal neurostimulator electrode array through skin 36 $282 $13,000
Fluoroscopic guidance for needle placement 35 $104 $450
Joint injection, major joint 34 $62 $300
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance 31 $193 $1,150
Daily hospital management of continuous spinal drug administration 22 $56 $350
Injection of trigger points, 3 or more muscles 19 $40 $306
Injection of substance into middle or upper spine canal using imaging guidance 19 $244 $2,055
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level 15 $104 $1,200
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 15 $533 $3,800
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 14 $299 $1,600
Insertion of spinal neurostimulator generator or receiver 13 $172 $5,350
Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin 11 $478 $3,282
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$78,637
Total received (2018-2024)
Avg $11,234/year across 7 years
Top 1% in TX for anesthesiology
20
Companies
277
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50,510 (64.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,316 (20.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,811 (15.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,924
2023
$18,252
2022
$34,892
2021
$1,917
2020
$1,470
2019
$2,284
2018
$2,899

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$28,177
GRT US Holding, Inc.
$24,825
Averitas Pharma Inc.
$10,465
Relievant Medsystems, Inc.
$2,760
Vertos Medical, Inc.
$2,276
Nuvectra Corporation
$2,040
Medtronic, Inc.
$1,539
MML US, Inc.
$1,340
Medtronic USA, Inc.
$1,258
Abbott Laboratories
$1,150
Boston Scientific Corporation
$855
Stratus Medical, LLC
$571
SPR Therapeutics, Inc
$511
Saluda Medical Americas, Inc.
$217
Vertiflex, Inc.
$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$143
Nalu Medical, Inc.
$140
Gilead Sciences, Inc.
$118
Siemens Medical Solutions USA, Inc.
$93
Allergan, Inc.
$15
Top 3 companies account for 80.7% of total payments
Associated products mentioned in payments ›
ACCURIAN · Algovita · Axium INS DRG IPG · BOTOX · CATALYFT PL EXPANDABLE INTERBODY SYSTEM · ETERNA · Epclusa · Evoke SCS · General - Pain Management · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · Nalu Neurostimulation System · Nimbus · Omnia · Proclaim Family of SCS IPGs · QUTENZA · Qutenza · RELISTOR · ReActiv8 · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · VANTA ADAPTIVESTIM · Vanta · WaveWriter Alpha Prime 16 · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for anesthesiology in TX.

Equivalent to $3,484 per 100 Medicare services performed
Looking for an anesthesiology specialist in Houston?
Compare anesthesiologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
1,122
Per 100K population
23.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pak is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with speaking/promotional industry engagement in the top 1% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pak experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Pak performed 759 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pak receive payments from pharmaceutical companies?
Yes. Dr. Pak received a total of $78,637 from 20 companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pak's costs compare to other anesthesiologists in Houston?
Dr. Pak's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →